v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Statement of Cash Flows [Abstract]    
Net loss $ (117,057,842) $ (21,462,354)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Bad debt expense 1,963,045 0
Amortization, deferred financing cost 428,282 91,108
Loss on debt extinguishment 4,826 0
Loss on settlement 60,414,821 0
Change in estimated fair value of contingent consideration 251,426 0
Change in fair value of warrants 2,428,727 0
Change in fair value of bifurcated derivatives 977,298 0
Loss on financing transaction 11,613,736 0
Gain on warrant exercise (639,808) 0
Payment of fee by issuance of Preferred Stock 239,192 0
Shares issued for services 75,000 326,400
Depreciation and amortization expense 8,765,901 2,469,138
Right-of-use asset amortization 1,062,361 867,432
Share-based compensation 4,603,918 12,309,724
Changes in operating assets and liabilities:    
Accounts receivable (12,321,266) 17,356,622
Contract assets 2,649,096 0
Unbilled accounts receivable (1,239,088) (44,838)
Prepaid expenses and other current assets (7,873,101) (715,739)
Due from related parties 6,781,398 (6,067,963)
Other assets (1,426,772) 101,536
Accounts payable 13,592,241 1,129,291
Due to related parties 714,984 (2,091,035)
Income taxes payable (3,071,521) 0
Accrued expenses and other current liabilities 12,715,733 1,630,927
Operating lease liability (394,418) (863,020)
Other liabilities (1,894,143) 0
Net cash provided by (used in) operating activities (13,732,690) 5,037,229
Cash flows from investing activities    
Purchase of property and equipment (80,529) (30,073)
Net cash (used in) investing activities (80,529) (30,073)
Cash flows from financing activities    
Acquisition, net - cash acquired 32,651,398 0
Borrowings on revolving line of credit 223,453,014 248,342,112
Payments on revolving line of credit (231,594,306) (253,464,848)
Payments on notes payable (1,520,022) 0
Proceeds from Factoring Agreements 1,000,000 0
Repayments on Factoring Debt 1,648,504 0
Other Short-Term Borrowings 3,050,000 0
Payments on factoring debt (570,157) 0
Proceeds from issuance of preferred stock and warrants, net of issuance costs 5,543,739 0
Proceeds received upon exercise of warrants 3,200,000 0
Debt issuance costs payment (40,500) (188,351)
Finance lease repayments (294,315) 0
Net cash (used in) provided by financing activities 33,230,347 (5,311,087)
Effect of exchange rates on cash and cash equivalents (173,167) 0
Net increase in cash and cash equivalents 19,243,961 (303,931)
Cash and Cash Equivalents – Beginning of period 81,134 678,676
Cash and Cash Equivalents – End of period 19,325,095 374,745
Cash paid during the period for:    
Interest 4,244,003 2,306,780
Non-cash investing and financing activities:    
Settlement shares issued to legacy stockholders 0 2,378,471
Share settled earnout value 5,600,000 0
Fair value of common shares issued as partial consideration for a business 48,312,030 0
Contingent consideration arrangement issued as partial consideration for a business 2,098,574 0
Fair value of convertible note issued as partial consideration for a business 205,706,131 0
Fair value of common shares issued to designee of the Circle8 Seller as partial consideration for a business 15,440,000 0
Refinancing of factoring agreements 2,221,965 0
Fair value of Common Stock issued to satisfy redemption of Series B Preferred Stock 9,981,037 0
Non-customer valuation allowance $ 2,903,284 $ 0